Intravenous Immune Globulin (IVIg) is an expensive and limited resource. It is prepared by several commercial manufacturers who use plasma derived from donors to produce IVIg
The BC Provincial Blood Coordinating Office (PBCO) operates an Immune Globulin (Ig) Utilization Management Program to ensure that enough IVIg and/or SCIg is available for patients likely to benefit from the treatment. The program incorporates the:
BC Ministry of Health Policy on Health Authority Immune Globulin Utilization Management Directives which requires that requests for IVIG use are screened in hospital Transfusion Medicine Services to make sure that IVIG is used in accordance with the BC IVIg Utilization Management Program Recommendations.
Two specialty panels support centralized screening. Additional information regarding the Rheumatology and Neurology Screening Programs are found on the following corresponding pages:
For recommendations related to the use of Ig, please visit the Recommendations Page.
